Trials / Terminated
TerminatedNCT05396755
Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)
Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis - a Multicenter, Randomized Controlled, Parallel Group Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Hannover Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, open-label, controlled, parallel group, multicenter clinical trial. Patients with confirmed secondary sclerosing cholangitis (SSC-CIP) will be randomized either in the intervention group undergoing scheduled invasive evaluation of the biliary tract or in the control group treated with non-interventional standard of care to demonstrate that programmed endoscopic therapy compared to a conservative strategy reduces the occurrence of treatment failures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endoscopic retrograde cholangiography (ERC) | invasive evaluation of the biliary tract with ERC and endoscopic interventions every 8 weeks until 6 months (24 weeks) |
Timeline
- Start date
- 2022-11-14
- Primary completion
- 2023-09-14
- Completion
- 2023-09-14
- First posted
- 2022-05-31
- Last updated
- 2023-10-11
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05396755. Inclusion in this directory is not an endorsement.